Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Price : 1.22 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.18 | 1.23 | 1.18 | 1.22 | 146207.0 |
| Sep 17, 2026 | 1.26 | 1.26 | 1.18 | 1.19 | 57025.00 |
| Sep 16, 2026 | 1.26 | 1.275 | 1.24 | 1.24 | 59768.00 |
| Sep 15, 2026 | 1.28 | 1.32 | 1.25 | 1.25 | 96168.00 |
| Sep 14, 2026 | 1.41 | 1.418 | 1.25 | 1.28 | 301511.0 |
| Sep 11, 2026 | 1.31 | 1.42 | 1.285 | 1.40 | 242659.0 |
| Sep 10, 2026 | 1.25 | 1.34 | 1.230 | 1.31 | 226758.0 |
| Sep 09, 2026 | 1.24 | 1.305 | 1.22 | 1.23 | 366566.0 |
| Sep 08, 2026 | 1.06 | 1.25 | 1.06 | 1.23 | 574177.0 |
| Sep 04, 2026 | 1.05 | 1.055 | 1.02 | 1.03 | 54229.00 |
| Sep 03, 2026 | 1.02 | 1.060 | 1.01 | 1.05 | 78757.00 |
| Sep 02, 2026 | 1.00 | 1.04 | 1.00 | 1.00 | 77574.00 |
| Sep 01, 2026 | 1.01 | 1.022 | 0.9955 | 0.9955 | 30067.00 |
| Aug 31, 2026 | 1.03 | 1.03 | 1.01 | 1.02 | 34778.00 |
| Aug 28, 2026 | 1.00 | 1.028 | 0.97 | 1.01 | 112016.0 |
| Aug 27, 2026 | 1.01 | 1.05 | 1.00 | 1.00 | 92868.00 |
| Aug 26, 2026 | 1.08 | 1.08 | 1.01 | 1.01 | 145245.0 |
| Aug 25, 2026 | 1.07 | 1.10 | 1.050 | 1.08 | 159003.0 |
| Aug 24, 2026 | 1.10 | 1.10 | 1.04 | 1.05 | 64454.00 |
| Aug 21, 2026 | 1.13 | 1.14 | 1.10 | 1.10 | 144008.0 |
| Aug 20, 2026 | 1.13 | 1.14 | 1.07 | 1.12 | 121417.0 |
| Aug 19, 2026 | 1.09 | 1.15 | 1.05 | 1.13 | 183407.0 |
| Aug 18, 2026 | 1.05 | 1.115 | 1.03 | 1.08 | 211197.0 |
| Aug 17, 2026 | 1.11 | 1.13 | 1.05 | 1.05 | 344942.0 |
| Aug 14, 2026 | 0.95 | 1.09 | 0.9350 | 1.04 | 490513.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| PE Ratio | 3.420 |
| PS Ratio | 1.087 |
| Price to Book Value | 1.266 |
| Earnings Yield | 29.24% |
| Market Cap | 38.36M |
| Operating PE Ratio | 3.991 |
| Normalized PE Ratio | 3.420 |